Articles tagged with Erbb Receptors
Researchers found that GZ17-6.02 killed uveal melanoma cells by enhancing autophagy, inactivating key proteins, and reducing growth factors. The compound also interacted with doxorubicin and ERBB inhibitors to enhance tumor cell killing, suggesting potential as a single agent or combination therapy.
Researchers at Stanford University School of Medicine have developed a synthetic biology approach that targets cancer cells with customizable treatments. The RASER system uses two proteins to kill only overly active cancer cells while sparing healthy ones, promising a more targeted and effective treatment.
Airway epithelial cells use a repair mechanism that is triggered when the cell barrier is breached, allowing messenger molecules to communicate with receptors and initiate rapid repair. This study suggests that certain diseases, such as asthma and cystic fibrosis, may impair this mechanism, leading to abnormal cellular changes.